热门资讯> 正文

Omeros 2025年第四季度盈利预览

2026-03-31 05:35

奥麦罗制药(OMER) 0

Omeros (OMER) is scheduled to announce Q4 earnings results on Monday, March 30th, after market close.
The consensus EPS Estimate is $0.36 (+166.7% Y/Y) and the consensus Revenue Estimate is $0M
Over the last 1 year, OMER has beaten EPS estimates 75% of the time and has beaten revenue estimates 0% of the time.

More on Omeros

Omeros: Yartemlea Can Own The Label And Still Split The Market
Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript
Omeros higher after first commercial sales of transplant therapy
Seeking Alpha’s Quant Rating on Omeros
Historical earnings data for Omeros

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。